Health & Personal Care
HIGH
FDA DRUG
Lupin Pharmaceuticals Recalls Ganirelix Acetate Injection for Impurity Risk
Lupin Pharmaceuticals recalled 32,736 vials of Ganirelix Acetate Injection on November 13, 2025. The recall follows the discovery of impurities in the drug. Consumers and healthcare providers should stop using the product immediately to avoid health risks.
GANIRELIX ACETATE
Failed impurities/degradation